|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocn846495244 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
130603s2013 gw a ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d COO
|d E7B
|d OCLCF
|d RIV
|d YDXCP
|d DEBSZ
|d IDEBK
|d OCLCQ
|d COCUF
|d MOR
|d CCO
|d PIFAG
|d ZCU
|d MERUC
|d OCLCQ
|d U3W
|d STF
|d WRM
|d NRAMU
|d ICG
|d INT
|d VT2
|d OCLCO
|d AU@
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCO
|d OCLCA
|d OCLCQ
|d DKC
|d OCLCQ
|d UKAHL
|d UKCRE
|d VLY
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
066 |
|
|
|c (S
|
015 |
|
|
|a GBB2A7777
|2 bnb
|
016 |
7 |
|
|a 101609992
|2 DNLM
|
016 |
7 |
|
|a 016196086
|2 Uk
|
019 |
|
|
|a 847138826
|a 961562803
|a 962701968
|a 988518494
|a 992074664
|a 1037784630
|a 1038597756
|a 1045505928
|a 1055327254
|a 1058164084
|a 1065682720
|a 1081265131
|a 1153546824
|a 1162584229
|a 1228570841
|a 1290097727
|a 1303514013
|
020 |
|
|
|a 9783527654215
|q (electronic bk.)
|
020 |
|
|
|a 3527654216
|q (electronic bk.)
|
020 |
|
|
|a 9781299633773
|q (MyiLibrary)
|
020 |
|
|
|a 1299633773
|q (MyiLibrary)
|
020 |
|
|
|z 9783527332007
|
020 |
|
|
|z 3527332006
|
020 |
|
|
|z 9783527654208
|q (ePub)
|
020 |
|
|
|z 9783527654192
|q (mobi)
|
020 |
|
|
|z 9783527654185
|q (oBook)
|
020 |
|
|
|a 3527654208
|
020 |
|
|
|a 9783527654208
|
020 |
|
|
|a 3527654186
|
020 |
|
|
|a 9783527654185
|
029 |
1 |
|
|a AU@
|b 000053030544
|
029 |
1 |
|
|a DEBBG
|b BV044175900
|
029 |
1 |
|
|a DEBSZ
|b 431429618
|
029 |
1 |
|
|a NZ1
|b 15348249
|
029 |
1 |
|
|a AU@
|b 000062469679
|
029 |
1 |
|
|a AU@
|b 000073077317
|
035 |
|
|
|a (OCoLC)846495244
|z (OCoLC)847138826
|z (OCoLC)961562803
|z (OCoLC)962701968
|z (OCoLC)988518494
|z (OCoLC)992074664
|z (OCoLC)1037784630
|z (OCoLC)1038597756
|z (OCoLC)1045505928
|z (OCoLC)1055327254
|z (OCoLC)1058164084
|z (OCoLC)1065682720
|z (OCoLC)1081265131
|z (OCoLC)1153546824
|z (OCoLC)1162584229
|z (OCoLC)1228570841
|z (OCoLC)1290097727
|z (OCoLC)1303514013
|
037 |
|
|
|a 494627
|b MIL
|
050 |
|
4 |
|a QP552.A45
|b A49 2013eb
|
060 |
|
4 |
|a 2013 E-919
|
060 |
|
4 |
|a QU 55
|
072 |
|
7 |
|a QP
|2 lcco
|
072 |
|
7 |
|a SCI
|x 007000
|2 bisacsh
|
082 |
0 |
4 |
|a 572.68
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Amyloid fibrils and prefibrillar aggregates :
|b molecular and biological properties /
|c edited by Daniel Erik Otzen.
|
260 |
|
|
|a Weinheim :
|b Wiley-VCH,
|c [2013]
|
300 |
|
|
|a 1 online resource (xxviii, 481 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
8 |
|
|a Summing up almost a decade of biomedical research, this topical handbook is a reference on the topic which incorporates recent breakthroughs in amyloid research. The first part covers the structural biology of amyloid fibrils and pre-fibrillar assemblies. The second part looks at the diagnosis and biomedical study of amyloid in humans and in animal models, while the final section discusses pharmacological approaches to manipulating amyloid.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Amyloid Fibrils and Prefibrillar Aggregates -- Contents -- Preface -- List of Contributors -- 1 The Amyloid Phenomenon and Its Significance -- 1.1 Introduction -- 1.2 The Nature of the Amyloid State of Proteins -- 1.3 The Structure and Properties of Amyloid Species -- 1.4 The Kinetics and Mechanism of Amyloid Formation -- 1.5 The Link between Amyloid Formation and Disease -- 1.6 Strategies for Therapeutic Intervention -- 1.7 Looking to the Future -- 1.8 Summary -- Acknowledgments -- References -- 2 Amyloid Structures at the Atomic Level: Insights from Crystallography -- 2.1 Atomic Structures of Segments of Amyloid-Forming Proteins -- 2.1.1 Protein Segments That Form Amyloid-Related Crystals -- 2.1.2 Atomic Structures of Fiber-Like Microcrystals -- 2.2 Stability of Amyloid Fibers -- 2.3 Which Proteins Enter the Amyloid State? -- 2.4 Molecular Basis of Amyloid Polymorphism and Prion Strains -- 2.5 Atomic Structures of Steric Zippers Suggest Models for Amyloid Fibers of Parent Proteins -- 2.6 Atomic Structures of Steric Zippers Offer Approaches for Chemical Interventions against Amyloid Formation -- 2.7 Summary -- Acknowledgments -- References -- 3 What Does Solid-State NMR Tell Us about Amyloid Structures? -- 3.1 Introduction -- 3.2 Principles of Solid-State NMR Spectroscopy and Experiments for Structural Constraints -- 3.2.1 Isotope Labeling, Magic Angle Spinning, Dipolar Coupling, and Resonance Assignment -- 3.2.2 De.ning the Amyloid Core by Magnetization Transfer from Water -- 3.2.3 Determining the Fibril Registry -- 3.2.4 Seeded versus Unseeded Fibrils -- 3.3 Amyloid Fibrils Investigated by Solid-State NMR Spectroscopy -- 3.3.1 AÝ peptides of Different Length -- 3.3.2 Islet Amyloid Polypeptide (IAPP/Amylin): Parallel and Antiparallel Steric Zippers -- 3.3.3 Ü-Synuclein: Polymorphism with Flexible Terminal Regions.
|
505 |
8 |
|
|a 3.3.4 PrP: Rearrangements to Maintain a Fibrillar Core Region -- 3.3.5 Yeast Prions with Glutamine/Asparagine-Rich Prion Domains: Sup35p, Ure2p, and Rnq1p -- 3.3.6 Functional Amyloid: the Yeast Prion HET-s -- 3.4 Summary -- References -- 4 From Molecular to Supramolecular Amyloid Structures: Contributions from Fiber Diffraction and Electron Microscopy -- 4.1 Introduction -- 4.2 History -- 4.2.1 The Historical Use of X-ray Fiber Diffraction -- 4.2.2 The Historical Use of Transmission Electron Microscopy -- 4.3 Methodology -- 4.3.1 X-Ray Fiber Diffraction -- 4.3.2 Transmission Electron Microscopy -- 4.4 Recent Advances in Amyloid Structure Determination -- 4.4.1 X-ray Fiber Diffraction -- 4.4.2 Transmission Electron Microscopy -- 4.5 Summary -- Acknowledgments -- References -- 5 Structures of Aggregating Species by Small-Angle X-Ray Scattering -- 5.1 Introduction -- 5.2 Theoretical and Experimental Aspects -- 5.3 Data Analysis and Modeling Methods -- 5.4 Studying Protein Aggregation and Fibrillation Using SAXS -- 5.4.1 Some General Considerations -- 5.4.2 SAXS Studies of Insulin, Glucagon, and Ü-Synuclein -- 5.4.3 SDS-Induced Aggregation of Ü-Synuclein -- 5.4.4 Multi-Component Fitting and Analysis of SAXS Data -- 5.5 General Strategies for Modeling SAXS Data from Protein Complexes -- 5.6 Summary and Final Remarks -- Acknowledgments -- References -- 6 Structural and Compositional Information about Pre-Amyloid Oligomers -- 6.1 General Introduction -- 6.2 Biophysical Techniques to Study Amyloid Oligomers -- 6.2.1 Fluorescence Spectroscopy -- 6.2.1.1 Ensemble Spectroscopy -- 6.2.1.2 Single-Molecule Spectroscopy -- 6.2.2 Atomic Force Microscopy -- 6.2.3 Absorbance and Circular Dichroism Spectroscopy -- 6.2.4 Small-Angle X-Ray Scattering -- 6.2.5 Mass Spectrometry -- 6.3 The Structure and Composition of Amyloid Oligomers -- 6.3.1 Ü-Synuclein Oligomers.
|
505 |
8 |
|
|a 6.3.1.1 Morphology -- 6.3.1.2 Oligomer Structure -- 6.3.1.3 Oligomer Composition -- 6.3.2 AÝ Peptide Oligomers -- 6.3.2.1 Morphology -- 6.3.2.2 Composition -- 6.4 Concluding Remarks -- Acknowledgments -- References -- 7 The Oligomer Species: Mechanistics and Biochemistry -- 7.1 Introduction -- 7.2 The Structure-Toxicity Relation of Early Amyloids -- 7.2.1 Antibodies Define Different Structural Classes of Oligomers and Fibrils -- 7.2.2 Proteins May Form Different Kinds of Oligomers with Different Structural and Biological Activities -- 7.3 The Oligomer-Membrane Complex -- 7.3.1 The Effect of Surfaces on Protein Misfolding and Aggregation -- 7.3.2 The Membrane Composition Affects Binding and Aggregation Processes -- 7.3.3 Complex Roles of Cholesterol and Gangliosides in Oligomer Cytotoxicity -- 7.4 Biochemical Modifications Underlying Amyloid Toxicity -- 7.4.1 A New View of the Amyloid Cascade Hypothesis -- 7.4.2 Amyloid Pores: a Mechanism for Cytotoxicity? -- 7.4.3 Other Mechanisms for Oligomer Cytotoxicity -- 7.4.3.1 Oxidative Stress and Amyloid Aggregates -- 7.4.3.2 Lipid Modification and Ca2+ Entry -- 7.4.3.3 The Complexity of Amyloid and Oligomer Polymorphism -- 7.5 Summary -- References -- 8 Pathways of Amyloid Formation -- 8.1 Introduction -- 8.2 Nomenclature of the Various Conformational States -- 8.3 Graphical Representations of the Mechanisms Leading to Amyloid -- 8.3.1 Time Course of Amyloid Content -- 8.3.2 Energy Landscapes of Amyloid Fibril Formation -- 8.3.3 Reaction Equilibria Involved in Amyloid Fibril Formation -- 8.4 Pathways of Amyloid Fibril Formation -- 8.5 Nucleation Growth versus Nucleated Conformational Conversion -- 8.6 Summary -- References -- 9 Sequence-Based Prediction of Protein Behavior -- 9.1 Introduction -- 9.2 The Strategy of the Zyggregator Predictions.
|
505 |
8 |
|
|a 9.2.1 Prediction of the Effects of Amino Acid Substitutions on Protein Aggregation Rates -- 9.2.2 Prediction of the Overall Aggregation Rates of Peptides and Proteins -- 9.2.3 Prediction of Aggregation-Prone Regions in Amino Acid Sequences -- 9.3 Aggregation Under Other Conditions -- 9.3.1 Prediction of Protein Aggregation-Prone Regions in the Presence of Denaturants -- 9.3.2 Prediction of Aggregation-Prone Regions in Native States of Proteins -- 9.4 Prediction of the Cellular Toxicity of Protein Aggregates -- 9.5 Relationship to Other Methods of Predicting Protein Aggregation Propensities -- 9.6 Competition between Folding and Aggregation of Proteins -- 9.7 Prediction of Protein Solubility from the Competition between Folding and Aggregation -- 9.7.1 Sequence-Based Prediction of Protein Solubility -- 9.7.2 Prediction of the Solubility of Proteins Based on Their Cellular Abundance -- 9.8 Sequence-Based Prediction of Protein Interactions with Molecular Chaperones -- 9.9 Summary -- References -- 10 The Kinetics and Mechanisms of Amyloid Formation -- 10.1 Introduction -- 10.2 Classical Theory of Nucleated Polymerization -- 10.2.1 From Microscopic Processes to a Master Equation -- 10.2.2 Kinetic Equations for Experimental Observables -- 10.2.3 Characteristics of Oosawa-Type Growth -- 10.2.3.1 Nucleation and Growth Occur Simultaneously -- 10.2.3.2 The Early Stages of the Reaction Time Course Are Described by Polynomial Growth -- 10.2.3.3 The Late Stages of the Reaction Time Course are Described by Simple First-Order Kinetics -- 10.2.3.4 The Integrated Rate Laws Exhibit Scaling Behavior -- 10.2.4 Global Analysis of Experimental Data Using the Oosawa Theory -- 10.3 The Theory of Filamentous Growth with Secondary Pathways -- 10.3.1 Extending the Oosawa Framework to Include Fragmentation and Secondary Nucleation -- 10.3.2 Early Time Perturbative Solutions.
|
505 |
8 |
|
|a 10.3.3 Characteristics of Exponential-Type Growth -- 10.3.3.1 The Early Stages of the Reaction Time Course Are Exponential -- 10.3.3.2 The Solution Exhibits Scaling Behavior -- 10.3.4 Global Analysis of Experimental Data Using Linearized Solutions -- 10.4 Self-Consistent Solutions for the Complete Reaction Time Course -- 10.4.1 The Key Phenomenological Parameters Depend on Combinations of the Microscopic Rate Constants -- 10.4.2 Reaction Time Course with Depleted Monomer Concentration -- 10.4.3 Global Analysis of Amyloid Reaction Kinetics Using Self-Consistent Solutions -- 10.5 Summary -- References -- 11 Fluorescence Spectroscopy as a Tool to Characterize Amyloid Oligomers and Fibrils -- 11.1 Introduction -- 11.2 Fluorescence Spectroscopy for Studies of Amyloid Reactions In vitro -- 11.2.1 Fluorescence Output Formats -- 11.2.2 Fluorescence Anisotropy -- 11.2.3 Single Molecule Detection -- 11.2.4 Conformational Probes -- 11.3 Cysteine-Reactive Fluorescent Probes -- 11.3.1 Environmentally Sensitive Probes -- Spectrochromic Stokes Shift Assay -- 11.3.2 Fluorescence Anisotropy Probes for Amyloid Oligomerization -- 11.3.3 Pyrene Excimer Formation Probes for amyloid Oligomer and Fibril Topology -- 11.3.4 Bifunctional Cysteine Reagents as Probes for Amyloid Oligomers and Fibrils -- 11.4 Amyloidotropic Probes for Amyloid Fibrils and Oligomeric States -- 11.4.1 Are There Selective Probes for Prefibrillar Oligomeric States? -- 11.4.2 Fluorescence Anisotropy of Small Molecule Probes for Capturing the Intermediate Oligomeric State -- 11.4.3 In vivo Fluorescent Probes for Amyloid Fibrils -- 11.5 Luminescent Conjugated Poly and Oligothiophenes LCPs and LCOs -- 11.5.1 Optical Properties of Chemically Defined LCOs -- 11.5.2 Bridging the Imaging and Spectroscopy Gap -- Microspectroscopy of In vivo Formed Amyloids.
|
546 |
|
|
|a English.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Amyloid.
|
650 |
1 |
2 |
|a Amyloid
|x chemistry
|
650 |
1 |
2 |
|a Amyloid
|x pharmacokinetics
|
650 |
|
2 |
|a Amyloid
|
650 |
|
6 |
|a Amyloïde.
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Biochemistry.
|2 bisacsh
|
650 |
|
7 |
|a Amyloid
|2 fast
|
650 |
|
7 |
|a Bioquímica.
|2 lemac
|
655 |
|
4 |
|a Llibres electrònics.
|
700 |
1 |
|
|a Otzen, Daniel Erik,
|d 1969-
|1 https://id.oclc.org/worldcat/entity/E39PCjvmw9rmgGQ39FcbPVmq8K
|
758 |
|
|
|i has work:
|a Amyloid fibrils and prefibrillar aggregates (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFKWW3htJKGCpbgRFWCKHP
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|t Amyloid fibrils and prefibrillar aggregates.
|d Weinheim : Wiley-VCH, [2013]
|z 9783527332007
|w (OCoLC)829054952
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1205604
|z Texto completo
|
880 |
8 |
|
|6 505-00/(S
|a 3 What Does Solid-State NMR Tell Us about Amyloid Structures3.1 Introduction; 3.2 Principles of Solid-State NMR Spectroscopy and Experiments for Structural Constraints; 3.2.1 Isotope Labeling, Magic Angle Spinning, Dipolar Coupling, and Resonance Assignment; 3.2.2 De.ning the Amyloid Core by Magnetization Transfer from Water; 3.2.3 Determining the Fibril Registry; 3.2.4 Seeded versus Unseeded Fibrils; 3.3 Amyloid Fibrils Investigated by Solid-State NMR Spectroscopy; 3.3.1 Aβ peptides of Different Length; 3.3.2 Islet Amyloid Polypeptide (IAPP/Amylin): Parallel and Antiparallel Steric Zippers.
|
880 |
8 |
|
|6 505-00/(S
|a 3.3.3 α-Synuclein: Polymorphism with Flexible Terminal Regions3.3.4 PrP: Rearrangements to Maintain a Fibrillar Core Region; 3.3.5 Yeast Prions with Glutamine/Asparagine-Rich Prion Domains: Sup35p, Ure2p, and Rnq1p; 3.3.6 Functional Amyloid: the Yeast Prion HET-s; 3.4 Summary; References; 4 From Molecular to Supramolecular Amyloid Structures: Contributions from Fiber Diffraction and Electron Microscopy; 4.1 Introduction; 4.2 History; 4.2.1 The Historical Use of X-ray Fiber Diffraction; 4.2.2 The Historical Use of Transmission Electron Microscopy; 4.3 Methodology; 4.3.1 X-Ray Fiber Diffraction.
|
880 |
8 |
|
|6 505-00/(S
|a 4.3.2 Transmission Electron Microscopy4.4 Recent Advances in Amyloid Structure Determination; 4.4.1 X-ray Fiber Diffraction; 4.4.2 Transmission Electron Microscopy; 4.5 Summary; Acknowledgments; References; 5 Structures of Aggregating Species by Small-Angle X-Ray Scattering; 5.1 Introduction; 5.2 Theoretical and Experimental Aspects; 5.3 Data Analysis and Modeling Methods; 5.4 Studying Protein Aggregation and Fibrillation Using SAXS; 5.4.1 Some General Considerations; 5.4.2SAXS Studies of Insulin, Glucagon, and α-Synuclein; 5.4.3SDS-Induced Aggregation of α-Synuclein.
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH26418077
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10716610
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 588000
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n cis25591180
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 9985335
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 10746539
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 12679471
|
994 |
|
|
|a 92
|b IZTAP
|